Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Reinhard Berner

Showing results (151-160 of 180) with videos related to

Pageof 18
Sort By:
Contemporary Clinical Trials Communications|February 7, 2025
Anti-viral action against type 1 diabetes autoimmunity: The GPPAD-AVAnT1A study protocolSandra Hummel, Alexandra Käßl, Stefanie Arnolds, et al.
The Journal of Clinical Investigation|October 17, 2022
Elevations in blood glucose before and after the appearance of islet autoantibodies in childrenKatharina Warncke, Andreas Weiss, Peter Achenbach, et al.
JMIR Medical Informatics|July 25, 2023
Interoperable, Domain-Specific Extensions for the German Corona Consensus (GECCO) COVID-19 Research Data Set Using an Interdisciplinary, Consensus-Based Workflow: Data Set Development StudyGregor Lichtner, Thomas Haese, Sally Brose, et al.
Infection|December 22, 2022
Neonatal invasive disease caused by Streptococcus agalactiae in Europe: the DEVANI multi-center studyFlorens Lohrmann, Markus Hufnagel, Mirjam Kunze, et al.
Digital Health|August 12, 2024
Secondary use of patient data within decentralized studies using the example of rare diseases in Germany: A data scientist's exploration of process and lessons learnedMichele Zoch, Christian Gierschner, Anne-Katrin Andreeff, et al.
BMC Pediatrics|February 2, 2020
Social inequalities in the participation and activity of children and adolescents with leukemia, brain tumors, and sarcomas (SUPATEEN): a protocol for a multicenter longitudinal prospective observational studyJulia Roick, Reinhard Berner, Toralf Bernig, et al.
Infection|February 14, 2023
Comparing SARS-CoV-2 variants among children and adolescents in Germany: relative risk of COVID-19-related hospitalization, ICU admission and mortalityMarietta Jank, Anna-Lisa Oechsle, Jakob Armann, et al.
Rheumatology (Oxford, England)|October 4, 2022
Novel mutation and expanding phenotype in IRF2BP2 deficiencyJulia Körholz, Anastasia Gabrielyan, Henrike Lisa Sczakiel, et al.
Lancet (London, England)|November 14, 2025
Efficacy of once-daily, high-dose, oral insulin immunotherapy in children genetically at risk for type 1 diabetes (POInT): a European, randomised, placebo-controlled, primary prevention trialAnette-Gabriele Ziegler, Peter Achenbach, Andreas Weiß, et al.
Infection|September 8, 2024
Maternal Streptococcus agalactiae colonization in Europe: data from the multi-center DEVANI studyFlorens Lohrmann, Androulla Efstratiou, Uffe B Skov Sørensen, et al.
Pageof 18

Showing results (151-160 of 180) with videos related to

Sort By:
Pageof 18
Contemporary Clinical Trials Communications|February 7, 2025
Anti-viral action against type 1 diabetes autoimmunity: The GPPAD-AVAnT1A study protocolSandra Hummel, Alexandra Käßl, Stefanie Arnolds, et al.
The Journal of Clinical Investigation|October 17, 2022
Elevations in blood glucose before and after the appearance of islet autoantibodies in childrenKatharina Warncke, Andreas Weiss, Peter Achenbach, et al.
JMIR Medical Informatics|July 25, 2023
Interoperable, Domain-Specific Extensions for the German Corona Consensus (GECCO) COVID-19 Research Data Set Using an Interdisciplinary, Consensus-Based Workflow: Data Set Development StudyGregor Lichtner, Thomas Haese, Sally Brose, et al.
Infection|December 22, 2022
Neonatal invasive disease caused by Streptococcus agalactiae in Europe: the DEVANI multi-center studyFlorens Lohrmann, Markus Hufnagel, Mirjam Kunze, et al.
Digital Health|August 12, 2024
Secondary use of patient data within decentralized studies using the example of rare diseases in Germany: A data scientist's exploration of process and lessons learnedMichele Zoch, Christian Gierschner, Anne-Katrin Andreeff, et al.
BMC Pediatrics|February 2, 2020
Social inequalities in the participation and activity of children and adolescents with leukemia, brain tumors, and sarcomas (SUPATEEN): a protocol for a multicenter longitudinal prospective observational studyJulia Roick, Reinhard Berner, Toralf Bernig, et al.
Infection|February 14, 2023
Comparing SARS-CoV-2 variants among children and adolescents in Germany: relative risk of COVID-19-related hospitalization, ICU admission and mortalityMarietta Jank, Anna-Lisa Oechsle, Jakob Armann, et al.
Rheumatology (Oxford, England)|October 4, 2022
Novel mutation and expanding phenotype in IRF2BP2 deficiencyJulia Körholz, Anastasia Gabrielyan, Henrike Lisa Sczakiel, et al.
Lancet (London, England)|November 14, 2025
Efficacy of once-daily, high-dose, oral insulin immunotherapy in children genetically at risk for type 1 diabetes (POInT): a European, randomised, placebo-controlled, primary prevention trialAnette-Gabriele Ziegler, Peter Achenbach, Andreas Weiß, et al.
Infection|September 8, 2024
Maternal Streptococcus agalactiae colonization in Europe: data from the multi-center DEVANI studyFlorens Lohrmann, Androulla Efstratiou, Uffe B Skov Sørensen, et al.
Pageof 18